Researchers Develop Mass Spec System for Discovery of Protein-Metabolite Interactions,Its developers have founded a...
Drug Discovery and Development
Cybin updates on its psychedelic-based therapeutics at R&D Day,Cybin provided an update on its...
100 top cell and gene therapy companies to watch in 2023,Discover the top 100...
QurAlis to tap $88M funding to develop ALS product candidates,QurAlis announced that it has...
This T-cell vaccine could be the future of COVID-19 protection,A new T-cell vaccine could...
PathAI debuts AISight digital pathology platform | DDD,PathAI has launched AISight, a digital pathology...
Antiviral ensitrelvir could shorten COVID-19 symptoms,The investigational antiviral ensitrelvir from Shionogi promises to accelerate...
Biofourmis and Chugai partner to on objective pain measure,Chugai and Biofourmis are collaborating to...
Reata sets $370,000 annual cost for new nerve disorder drug,Reata Pharmaceuticals has won FDA...
An executive’s journey to marketing director at Biomerica,We recently spoke with Astrid Stark, marketing...
How automation is changing the face of pharmacovigilance,The ever-growing volume of data from clinical...
AbbVie's working with Dare to Dream Project on pediatric leukemia,AbbVie Oncology recently joined the...
25 novel therapies set to shape the landscape of medicine in 2023,The year 2023...
Algernon to explore psychedelic as traumatic brain injury treatment,Algernon announced its plans to explore...
AbbVie and Capsida join forces to focus on serious eye diseases,AbbVie will work with...
Elranatamab wins priority review from FDA for multiple myeloma,FDA has granted priority review to...
The psoriasis medication apremilast could hold promise in AUD,The scientists tested apremilast in a...
Kendall Square-based LabCentral gaining traction in biotech,The model from LabCentral supports creative academics' quest...
CMS restricts coverage of amyloid-targeting Alzheimer's antibodies,CMS has denied the Alzheimer's Association's request asking...
Vir Biotechnology parts from GSK on next-gen COVID-19 therapies,Vir Biotechnology has amended its research...
